Christopher Von Seggern

Insider Reports History

Location
Burnaby, British Columbia, Canada
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Von Seggern:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Chief Commercial Officer Stock Option (Right to Buy) 100,000 11 Mar 2024 Direct

Insider Reports Filed by Christopher Von Seggern

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XENE Xenon Pharmaceuticals Inc. 11 Mar 2024 1 $0 4 Chief Commercial Officer 12 Mar 2024, 18:42
XENE Xenon Pharmaceuticals Inc. 10 Mar 2023 1 $0 4 Chief Commercial Officer 14 Mar 2023, 16:47
XENE Xenon Pharmaceuticals Inc. 10 Mar 2022 1 $0 4 Chief Commercial Officer 14 Mar 2022, 16:24
XENE Xenon Pharmaceuticals Inc. 06 Dec 2021 1 +$97,600 4 Chief Commercial Officer 07 Dec 2021, 15:13